Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 7241Neoplasms 4538Prostatic Neoplasms 3489Colorectal Neoplasms 2939Carcinoma, Non-Small-Cell Lung 2829Lung Neoplasms 2546Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1873Multiple Myeloma 1810Carcinoma, Hepatocellular 1732Neoplasm Metastasis 1585Stomach Neoplasms 1501Lymphoma 1456Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1434Brain Neoplasms 1370Melanoma 1346Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1254Colonic Neoplasms 1204Glioblastoma 1137Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1065Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

sotigalimab 1Surgical Procedures, Operative 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Locally Advanced Rectal Adenocarcinoma × Clear all
NCT07596290 2026-05-22

RADICAL

Beijing Friendship Hospital

Phase 2/3 Not yet recruiting
342 enrolled
Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

NCT04130854 2026-05-06

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
58 enrolled
Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

NCT07200141 2025-09-30

SIB-NCRT-pumch

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
156 enrolled
Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡